Relay Therapeutics Inc. RLAY
$15.10
▲ +4.00% 24H
About
Relay Therapeutics Inc. is a clinical-stage precision medicine company focused on transforming drug discovery through its proprietary Dynamo platform, which integrates computational modeling, machine learning, and experimental approaches to target dynamic protein motions for small molecule therapeutics. The company spe…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees193
TickerRLAY
Statistics
Market Cap$2.86B
Revenue (TTM)$15.4M
Net Income-$276.5M
Net Margin-1800.6%
EPS$-1.61
P/E-9.19
P/S275.39
P/B3.97
EV/EBITDA-6.72
ROE-40.0%
Dividend Yield—
Price$15.10
Data: Twelve Data · Revenue = mcap / P/S